AVE vs NAN

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

46LOW

NAN

NANOSONICS FPO [NAN]

46LOW

Score Breakdown

AVE NAN
Technical
66
61
Catalyst
54
50
Sentiment
50
50
Fundamental
54
87
Momentum
71
41
Risk Gate
35
40

Key Metrics

AVE Metric NAN
$33.1MMarket Cap$1.1B
7.9MAvg Volume (20d)1.1M
N/AShort Interest+11.7%
$0.01252-Week High$5.080
$0.00452-Week Low$3.210
+0.0%Daily Change+3.0%
$0.009Entry Price$3.615
-182.9%ROE+10.1%
N/AProfit Margin+9.9%

Active Signals

AVE Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-17%)
●Small-cap ($20-100M)

NAN Signals

●MACD momentum is picking up steam
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.3x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare AVE and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
AVE Full Analysis → NAN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).